Found: 67
Select item for more details and to access through your institution.
Pro pacienty s roztroušenou sklerózou je klíčová vysoce efektivní léčba od počátku nemoci, vakcinaci je třeba individuálně zvažovat.
- Published in:
- Remedia, 2023, v. 33, n. 5, p. 369
- By:
- Publication type:
- Article
Komentář: Proč bylo třeba vydat nový klinický doporučený postup?
- Published in:
- Remedia, 2024, v. 34, n. 1, p. 51
- By:
- Publication type:
- Article
Ponesimod.
- Published in:
- Remedia, 2022, v. 32, n. 6, p. 521
- By:
- Publication type:
- Article
Komentář: Ofatumumab - nová vysoce účinná léčba dostupná pro pacienty s relabující roztroušenou sklerózou.
- Published in:
- Remedia, 2022, v. 32, n. 3, p. 256
- By:
- Publication type:
- Article
Kontrola komorbidit zlepšuje kvalitu života pacientů.
- Published in:
- Remedia, 2021, v. 31, n. 6, p. 518
- By:
- Publication type:
- Article
Cesta k oddálení progrese u pacientů s roztroušenou sklerózou.
- Published in:
- Remedia, 2021, v. 31, n. 4, p. 367
- By:
- Publication type:
- Article
Ofatumumab.
- Published in:
- Remedia, 2021, v. 31, n. 3, p. 264
- By:
- Publication type:
- Article
The clinical and paraclinical correlates of employment status in multiple sclerosis.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 3, p. 1911, doi. 10.1007/s10072-021-05553-z
- By:
- Publication type:
- Article
Additive Effect of Spinal Cord Volume, Diffuse and Focal Cord Pathology on Disability in Multiple Sclerosis.
- Published in:
- Frontiers in Neurology, 2019, p. 1, doi. 10.3389/fneur.2019.00820
- By:
- Publication type:
- Article
The potential of serum neurofilament as biomarker for multiple sclerosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Early clinical markers of aggressive multiple sclerosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Brainstem lesions are associated with diffuse spinal cord involvement in early multiple sclerosis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Interpretation of Brain Volume Increase in Multiple Sclerosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Role of High-Frequency MRI Monitoring in the Detection of Brain Atrophy in Multiple Sclerosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis.
- Published in:
- PLoS ONE, 2024, v. 19, n. 3, p. 1, doi. 10.1371/journal.pone.0300914
- By:
- Publication type:
- Article
Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864231221331
- By:
- Publication type:
- Article
The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021.
- Published in:
- Biomedical Papers of the Medical Faculty of Palacky University in Olomouc, 2024, v. 168, n. 3, p. 262, doi. 10.5507/bp.2023.015
- By:
- Publication type:
- Article
Comparative effectiveness in multiple sclerosis: A methodological comparison.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 3, p. 326, doi. 10.1177/13524585231151394
- By:
- Publication type:
- Article
Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 11, p. 1752, doi. 10.1177/13524585221084577
- By:
- Publication type:
- Article
Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 842, doi. 10.1177/13524585211061335
- By:
- Publication type:
- Article
Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 13, p. 2001, doi. 10.1177/13524585211047977
- By:
- Publication type:
- Article
Determinants of therapeutic lag in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 12, p. 1838, doi. 10.1177/1352458520981300
- By:
- Publication type:
- Article
The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 479, doi. 10.1177/1352458520930620
- By:
- Publication type:
- Article
Neurofilament levels are associated with blood–brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 2, p. 220, doi. 10.1177/1352458520912379
- By:
- Publication type:
- Article
Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 1, p. 52, doi. 10.1177/1352458519901272
- By:
- Publication type:
- Article
Risk of secondary progressive multiple sclerosis: A longitudinal study.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 1, p. 79, doi. 10.1177/1352458519868990
- By:
- Publication type:
- Article
Incidence, management, and outcomes of autoimmune nephropathies following alemtuzumab treatment in patients with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 9, p. 1273, doi. 10.1177/1352458519841829
- By:
- Publication type:
- Article
Pathological cut-offs of global and regional brain volume loss in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 541, doi. 10.1177/1352458517742739
- By:
- Publication type:
- Article
Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 14, p. 1883, doi. 10.1177/1352458517735190
- By:
- Publication type:
- Article
Využití krokoměrů pro zvýšení pohybové aktivity a ovlivnění chůze u pacientů s roztroušenou sklerózou, pilotní studie.
- Published in:
- Medicina Sportiva Bohemica et Slovaca, 2019, v. 28, n. 1, p. 2
- By:
- Publication type:
- Article
Flow Cytometry Analysis of Blood Large Extracellular Vesicles in Patients with Multiple Sclerosis Experiencing Relapse of the Disease.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 10, p. 2832, doi. 10.3390/jcm11102832
- By:
- Publication type:
- Article
Multiple Sclerosis and Microbiome.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 3, p. 433, doi. 10.3390/biom12030433
- By:
- Publication type:
- Article
Using Serum Metabolomics to Predict Development of Anti-drug Antibodies in Multiple Sclerosis Patients Treated With IFNβ.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.01527
- By:
- Publication type:
- Article
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts.
- Published in:
- CNS Drugs, 2021, v. 35, n. 11, p. 1217, doi. 10.1007/s40263-021-00860-7
- By:
- Publication type:
- Article
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2023, v. 80, n. 7, p. 702, doi. 10.1001/jamaneurol.2023.1184
- By:
- Publication type:
- Article
Association of Pregnancy With the Onset of Clinically Isolated Syndrome.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 12, p. 1496, doi. 10.1001/jamaneurol.2020.3324
- By:
- Publication type:
- Article
Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 11, p. 1398, doi. 10.1001/jamaneurol.2020.2453
- By:
- Publication type:
- Article
Cognitive clinico‐radiological paradox in early stages of multiple sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2018, v. 5, n. 1, p. 81, doi. 10.1002/acn3.512
- By:
- Publication type:
- Article
Brain MRI disease burden and sex differences in cognitive performance of patients with multiple sclerosis.
- Published in:
- Acta Neurologica Belgica, 2024, v. 124, n. 1, p. 109, doi. 10.1007/s13760-023-02350-7
- By:
- Publication type:
- Article
Tract-wise microstructural analysis informs on current and future disability in early multiple sclerosis.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 2, p. 631, doi. 10.1007/s00415-023-12023-3
- By:
- Publication type:
- Article
Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 3, p. 1670, doi. 10.1007/s00415-021-10836-8
- By:
- Publication type:
- Article
Long-term safety and efficacy of daclizumab beta in relapsing–remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study.
- Published in:
- Journal of Neurology, 2020, v. 267, n. 10, p. 2851, doi. 10.1007/s00415-020-09835-y
- By:
- Publication type:
- Article
Multiple Sclerosis Relapses Following Cessation of Fingolimod.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 4, p. 355, doi. 10.1007/s40261-022-01129-7
- By:
- Publication type:
- Article
Effects of Menopause in Women With Multiple Sclerosis: An Evidence-Based Review.
- Published in:
- Frontiers in Neurology, 2021, v. 11, p. N.PAG, doi. 10.3389/fneur.2021.554375
- By:
- Publication type:
- Article
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 4, p. 1014, doi. 10.1111/ene.15706
- By:
- Publication type:
- Article
Confirmed disability progression as a marker of permanent disability in multiple sclerosis.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 8, p. 2321, doi. 10.1111/ene.15406
- By:
- Publication type:
- Article
Pregnancy‐induced brain magnetic resonance imaging changes in women with multiple sclerosis.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 5, p. 1446, doi. 10.1111/ene.15245
- By:
- Publication type:
- Article
Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 4, p. 1082, doi. 10.1111/ene.14824
- By:
- Publication type:
- Article
(DXT77) Alemtuzumab Maintains Efficacy on Clinical and Magnetic Resonance Imaging Lesion Outcomes, Including Slowing of Brain Volume Loss, Over 9 Years in Relapsing-Remitting Multiple Sclerosis Patients: CARE-MS II Follow-up (TOPAZ Study).
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 43
- By:
- Publication type:
- Article
Rehabilitace pacientů, kteří onemocněli covidem-19 (příklad osob s roztroušenou sklerózou).
- Published in:
- Neurologie Pro Praxi, 2022, v. 23, n. 1, p. 84, doi. 10.36290/neu.2022.004
- By:
- Publication type:
- Article